Accenture Makes Strategic Investment in ixlayer to Expand Access to Virtual Diagnostic Health Testing
NEW YORK; Aug. 24, 2021 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in ixlayer, a provider of technology-based solutions for diagnostic testing. The company’s telehealth platform allows players across the healthcare ecosystem to offer convenient and scalable health testing in a virtual environment.
Comments
Post a Comment